CVE-2016-8355An issue was discovered in Smiths-Medical CADD-Solis Medication Safety Software, Version 1.0; 2.0; 3.0; and 3.1.
Updated under an hour ago ()
Does this affect you?
It affects smiths-medical cadd-solis_medication_safety_software. Add what you run to find out whether that includes you.
EPSS puts the chance of exploitation in the next 30 days at 1.49%, higher than 74% of scored CVEs.
Do this next
Free account, 1 product
An issue was discovered in Smiths-Medical CADD-Solis Medication Safety Software, Version 1.0; 2.0; 3.0; and 3.1. CADD-Solis Medication Safety Software grants an authenticated user elevated privileges on the SQL database, which would allow an authenticated user to modify drug libraries, add and delete users, and change user permissions. According to Smiths-Medical, physical access to the pump is required to install drug library updates.
- CVSS
- 9.9 CRITICAL (v3.0, NVD)CVSS:3.0/AV:N/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:H
- Weakness (CWE)
- Not given
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- 1.49% (percentile 74)
- Assigned by
- icscert
- NVD analysis
- Modified
- Record last updated
- Aug 6, 2024
- First seen by InfoSec Signals
- Oct 12, 2026
Affected products
smiths-medical cadd-solis_medication_safety_software smiths-medical:cadd-solis_medication_safety_software | 1.0; 2.0; 3.0; 3.1 | NVD |
References
- https://ics-cert.us-cert.gov/advisories/ICSMA-16-306-01x-refsource-misc, third-party-advisory, us-government-resource
- http://www.securityfocus.com/bid/94630vdb-entry, x-refsource-bid, third-party-advisory
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.